4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-034027
Chief Medical Officer acquired 80,645 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baffa Raffaele Chief Medical Officer | 2021-05-17 | Grant or award | +80,645 | 280,645 | D |
Loading xslF345X03/doc4.xml…